Histidine residues at the copper-binding site in human tyrosinase are essential for its catalytic activities
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Noh, Hyangsoon | - |
dc.contributor.author | Lee, Sung Jun | - |
dc.contributor.author | Jo, Hyun-Joo | - |
dc.contributor.author | Choi, Hye Won | - |
dc.contributor.author | Hong, Sungguan | - |
dc.contributor.author | Kong, Kwang-Hoon | - |
dc.date.available | 2020-04-17T02:20:14Z | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 1475-6366 | - |
dc.identifier.issn | 1475-6374 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/38547 | - |
dc.description.abstract | Tyrosinase is a copper-binding enzyme involved in melanin biosynthesis. However, the detailed structure of human tyrosinase has not yet been solved, along with the identification of the key sites responsible for its catalytic activity. We used site-directed mutagenesis to identify the residues critical for the copper binding of human tyrosinase. Seven histidine mutants in the two copper-binding sites were generated, and catalytic activities were characterised. The tyrosine hydroxylase activities of the CuA site mutants were approximately 50% lower than those of the wild-type tyrosinase, while the dopa oxidation activities of the mutants were not significantly different from that of wild-type tyrosinase. By contrast, mutations at CuB significantly decreased both tyrosine hydroxylation and dopa oxidation activities, confirming that the catalytic sites for these two activities are at least partially distinct. These findings provide a useful resource for further structural determination and development of tyrosinase inhibitors in the cosmetic and pharmaceutical industries. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Taylor and Francis Ltd | - |
dc.title | Histidine residues at the copper-binding site in human tyrosinase are essential for its catalytic activities | - |
dc.type | Article | - |
dc.identifier.doi | 10.1080/14756366.2020.1740691 | - |
dc.identifier.bibliographicCitation | Journal of Enzyme Inhibition and Medicinal Chemistry, v.35, no.1, pp 726 - 732 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000560171400001 | - |
dc.identifier.scopusid | 2-s2.0-85081919246 | - |
dc.citation.endPage | 732 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 726 | - |
dc.citation.title | Journal of Enzyme Inhibition and Medicinal Chemistry | - |
dc.citation.volume | 35 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | active site | - |
dc.subject.keywordAuthor | CuA and CuB binding site | - |
dc.subject.keywordAuthor | histidine residues | - |
dc.subject.keywordAuthor | Human tyrosinase | - |
dc.subject.keywordAuthor | site-directed mutagenesis | - |
dc.subject.keywordPlus | CRYSTAL-STRUCTURE | - |
dc.subject.keywordPlus | POLYPHENOL OXIDASE | - |
dc.subject.keywordPlus | CATECHOL OXIDASE | - |
dc.subject.keywordPlus | MECHANISM | - |
dc.subject.keywordPlus | INSIGHTS | - |
dc.subject.keywordPlus | MELANIN | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | LATENT | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.